• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of neoadjuvant therapy on postoperative outcomes following sleeve lobectomy for locally advanced non-small cell lung cancer: a call for future investigation.

作者信息

Jindani Rajika, Stiles Brendon

机构信息

Department of Cardiovascular and Thoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY, USA.

出版信息

J Thorac Dis. 2024 Apr 30;16(4):2687-2689. doi: 10.21037/jtd-23-1982. Epub 2024 Apr 18.

DOI:10.21037/jtd-23-1982
PMID:38738233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11087602/
Abstract
摘要

相似文献

1
The impact of neoadjuvant therapy on postoperative outcomes following sleeve lobectomy for locally advanced non-small cell lung cancer: a call for future investigation.新辅助治疗对局部晚期非小细胞肺癌肺叶切除术后结局的影响：呼吁未来开展研究
J Thorac Dis. 2024 Apr 30;16(4):2687-2689. doi: 10.21037/jtd-23-1982. Epub 2024 Apr 18.
2
Neoadjuvant therapy does not increase postoperative morbidity of sleeve lobectomy in locally advanced non-small cell lung cancer.新辅助治疗不会增加局部晚期非小细胞肺癌袖状肺叶切除术的术后发病率。
J Thorac Cardiovasc Surg. 2023 Oct;166(4):1234-1244.e13. doi: 10.1016/j.jtcvs.2023.03.016. Epub 2023 Mar 24.
3
Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.袖状肺叶切除术治疗非小细胞肺癌和低度肿瘤的长期结果。
Ann Thorac Surg. 2009 Nov;88(5):1574-81; discussion 1581-2. doi: 10.1016/j.athoracsur.2009.07.060.
4
[Carinal resection and reconstruction combined with heart and great vessel plasty in the treatment of locally advanced non-small cell lung cancer].隆突切除重建联合心脏及大血管成形术治疗局部晚期非小细胞肺癌
Zhongguo Fei Ai Za Zhi. 2006 Feb 20;9(1):2-8. doi: 10.3779/j.issn.1009-3419.2006.01.02.
5
[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].基于分子分期的局部晚期非小细胞肺癌个体化手术治疗的长期生存
Zhongguo Fei Ai Za Zhi. 2011 Feb;14(2):86-106. doi: 10.3779/j.issn.1009-3419.2011.02.15.
6
Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer.新辅助化疗后非小细胞肺癌患者行双袖式肺叶切除术的可行性。
Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2). doi: 10.1093/icvts/ivac103.
7
Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer.新辅助化疗免疫治疗/化疗后行袖式肺叶切除术治疗局部晚期非小细胞肺癌
Transl Lung Cancer Res. 2021 Jan;10(1):143-155. doi: 10.21037/tlcr-20-778.
8
Neoadjuvant chemoimmunotherapy confers survival advantage for patients undergoing sleeve lobectomy.新辅助化疗免疫治疗可为接受袖状肺叶切除术的患者带来生存优势。
Eur J Cardiothorac Surg. 2024 Mar 29;65(4). doi: 10.1093/ejcts/ezae125.
9
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.新辅助放化疗后，袖状肺叶切除术后围手术期吻合口并发症的发生率并未增加。
Ann Thorac Surg. 2009 Sep;88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.
10
Neoadjuvant therapy and sleeve lobectomy for locally advanced non-small cell lung cancer: morbidity and survival balancing.局部晚期非小细胞肺癌的新辅助治疗与袖式肺叶切除术：发病率与生存的平衡
J Thorac Dis. 2024 Apr 30;16(4):2690-2693. doi: 10.21037/jtd-24-23. Epub 2024 Apr 10.

本文引用的文献

1
Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A review.了解早期非小细胞肺癌临床试验中使用的与健康相关的生活质量测量方法：综述。
Lung Cancer. 2024 Jan;187:107419. doi: 10.1016/j.lungcan.2023.107419. Epub 2023 Nov 10.
2
Association of socioeconomic factors with the receipt of neoadjuvant therapy for patients with non-small cell lung cancer.社会经济因素与非小细胞肺癌患者接受新辅助治疗之间的关联。
J Thorac Cardiovasc Surg. 2024 Apr;167(4):1458-1466.e4. doi: 10.1016/j.jtcvs.2023.09.033. Epub 2023 Sep 21.
3
Underutilization of Systemic Therapy in Patients With NSCLC Undergoing Pneumonectomy: A Missed Opportunity for Survival.接受肺切除术的非小细胞肺癌患者全身治疗的利用不足：生存的错失机遇。
JTO Clin Res Rep. 2023 Jun 30;4(8):100547. doi: 10.1016/j.jtocrr.2023.100547. eCollection 2023 Aug.
4
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.美国胸外科学会（AATS）2023 年专家共识文件：早期非小细胞肺癌患者的分期和多学科管理。
J Thorac Cardiovasc Surg. 2023 Sep;166(3):637-654. doi: 10.1016/j.jtcvs.2023.04.039. Epub 2023 Jun 10.
5
Neoadjuvant therapy does not increase postoperative morbidity of sleeve lobectomy in locally advanced non-small cell lung cancer.新辅助治疗不会增加局部晚期非小细胞肺癌袖状肺叶切除术的术后发病率。
J Thorac Cardiovasc Surg. 2023 Oct;166(4):1234-1244.e13. doi: 10.1016/j.jtcvs.2023.03.016. Epub 2023 Mar 24.
6
Sleeve lobectomy in patients with non-small-cell lung cancer: a report from the European Society of Thoracic Surgery database 2021.袖状肺叶切除术治疗非小细胞肺癌患者：欧洲胸外科协会数据库 2021 年报告。
Eur J Cardiothorac Surg. 2022 Nov 3;62(6). doi: 10.1093/ejcts/ezac502.
7
Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer.非小细胞肺癌新辅助免疫治疗专家共识
Transl Lung Cancer Res. 2020 Dec;9(6):2696-2715. doi: 10.21037/tlcr-2020-63.
8
Outcomes of sleeve lobectomy versus pneumonectomy: A propensity score-matched study.袖状肺叶切除术与全肺切除术的结果比较：一项倾向评分匹配研究。
J Thorac Cardiovasc Surg. 2021 Dec;162(6):1619-1628.e4. doi: 10.1016/j.jtcvs.2020.08.027. Epub 2020 Aug 14.
9
Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis.袖状肺叶切除术与全肺切除术治疗可手术切除的中央型非小细胞肺癌的Meta分析
Transl Lung Cancer Res. 2019 Dec;8(6):775-786. doi: 10.21037/tlcr.2019.10.11.
10
Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.N2期非小细胞肺癌新辅助同步放化疗后手术的疗效
Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.